Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Prevention | 114 |
| Treatment | 60 |
| Diagnostic | 7 |
| Health Services Research | 7 |
| Other | 7 |
| NA | 7 |
| Basic Science | 4 |
| Supportive Care | 2 |
| Screening | 1 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 347 |
| interventional | 209 |
| Observational | 124 |
| Registry | 14 |
```
| intervention_type | Study_Count |
|---|---|
| Drug | 128 |
| Drug|placebo | 26 |
| Other | 15 |
| Device | 14 |
| Behavioral | 10 |
| Drug|Other | 3 |
| Procedure | 3 |
| Device|Drug | 2 |
| Behavioral|Other | 1 |
| Biological | 1 |
| Biological|Drug | 1 |
| Biological|Genetic | 1 |
| Device|Other | 1 |
| Diagnostic Test|Drug | 1 |
| Drug|Procedure | 1 |
| Genetic|Other | 1 |
| Country | Study_Count |
|---|---|
| United States | 51 |
| Canada | 20 |
| Japan | 13 |
| France | 12 |
| Italy | 8 |
| NA | 6 |
| Switzerland | 5 |
| China | 4 |
| Korea, Republic of | 4 |
| United States|Canada | 4 |
| Brazil | 2 |
| Finland | 2 |
| Japan|Taiwan | 2 |
| Sweden | 2 |
| Argentina|Bulgaria|Chile|Colombia|Czech Republic|Denmark|Finland|Mexico|Norway|Poland|Romania|Russian Federation|Sweden|Turkey | 1 |
| Argentina|Bulgaria|Chile|Colombia|Denmark|Finland|Greece|Malaysia|Mexico|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Sweden|Taiwan|Thailand|Turkey | 1 |
| Argentina|United States|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|India|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Portugal|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom | 1 |
| Australia|Austria|Belgium|Czech Republic|Denmark|Finland|France|Germany|Hungary|Italy|Netherlands|Norway|Poland|South Africa|Spain|Sweden | 1 |
| Australia|Germany|Mexico|Spain|United Kingdom | 1 |
| Austria|Belgium|Canada|China|Colombia|Czech Republic|Denmark|France|Germany|Israel|Italy|Mexico|Netherlands|Norway|Peru|Poland|South Africa|Spain|Sweden | 1 |
| Austria|Belgium|Denmark|France|Germany|Israel|Italy|Netherlands|Norway|Poland|Spain|Sweden|United Kingdom | 1 |
| Austria|Canada|Czechia|Finland|Netherlands|Sweden | 1 |
| Austria|Germany|Netherlands | 1 |
| Belgium|Austria|Czech Republic|Denmark|Finland|France|Hungary|Italy|Netherlands|Norway|South Africa|Sweden | 1 |
| Belgium|United States|Argentina|Australia|Austria|Brazil|Canada|China|Finland|France|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Mexico|Netherlands|Portugal|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom | 1 |
| Bulgaria|Canada|Latvia|Russian Federation|Ukraine | 1 |
| Bulgaria|Latvia|Lithuania|Poland|Ukraine | 1 |
| Canada|France|Russian Federation | 1 |
| Canada|Italy|Lithuania|Russian Federation|Switzerland|Thailand | 1 |
| Canada|Netherlands|Switzerland | 1 |
| Canada|New Zealand | 1 |
| Canada|Norway | 1 |
| Colombia | 1 |
| Czech Republic|Denmark|Norway|Sweden | 1 |
| Czechia|Bulgaria|Canada|Greece|Israel|Latvia|Lithuania|Poland|Portugal|Russian Federation|South Africa|Spain|Ukraine | 1 |
| Denmark | 1 |
| Denmark|United States|Australia|Austria|Bosnia and Herzegovina|Brazil|Canada|Colombia|Czech Republic|Estonia|Finland|Germany|Hungary|India|Israel|Italy|Latvia|Lithuania|Norway|Poland|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Ukraine|United Kingdom | 1 |
| France|Finland|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|Czech Republic|Denmark|Germany|Greece|Hungary|Israel|Italy|Lithuania|Mexico|Netherlands|Norway|Poland|Slovakia|South Africa|Spain|Sweden|Turkey | 1 |
| France|Monaco | 1 |
| France|Romania|Ukraine|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|Estonia|Finland|Georgia|Germany|Hungary|Israel|Italy|Latvia|Lithuania|Montserrat|Peru|Poland|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|United Kingdom | 1 |
| France|Spain|Sweden|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Estonia|Finland|Germany|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Luxembourg|Malaysia|Mexico|Netherlands|New Zealand|Norway|Pakistan|Peru|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Slovenia|South Africa|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| France|Switzerland | 1 |
| France|United States|Belgium|Brazil|Bulgaria|Canada|Czechia|Germany|Russian Federation|United Kingdom | 1 |
| Germany | 1 |
| Greece|Netherlands | 1 |
| Hong Kong | 1 |
| Indonesia|Japan|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan|Thailand | 1 |
| Israel|Italy|United States|Belgium|France|Germany|Netherlands|Poland|Portugal|Spain|United Kingdom | 1 |
| Japan|Korea, Republic of|Taiwan|Thailand | 1 |
| Japan|Taiwan|Thailand | 1 |
| Lebanon | 1 |
| Netherlands | 1 |
| Portugal|Romania|Russian Federation|Spain | 1 |
| Russian Federation | 1 |
| Saudi Arabia | 1 |
| Spain | 1 |
| Spain|Austria|Belgium|Denmark|France|Germany|Israel|Italy|Netherlands|Norway|Poland|Sweden|United Kingdom | 1 |
| Sweden|United Kingdom | 1 |
| United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Indonesia|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|China|Croatia|Czech Republic|Denmark|Estonia|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Norway|Peru|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Colombia|France|Germany|India|Israel|Italy|Mexico|Poland|Russian Federation|South Africa|Spain|Tunisia|United Kingdom | 1 |
| United States|Argentina|Australia|Belarus|Canada|Chile|Colombia|Czech Republic|Denmark|Estonia|Finland|Germany|Greece|India|Italy|Mexico|Norway|Peru|Philippines|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine | 1 |
| United States|Argentina|Australia|Belarus|Canada|Colombia|Czech Republic|Denmark|Estonia|Greece|Lithuania|Mexico|Poland|Romania|Russian Federation|South Africa|Ukraine | 1 |
| United States|Argentina|Austria|Belgium|Brazil|Canada|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Mexico|Norway|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine | 1 |
| United States|Argentina|Belarus|Bulgaria|Canada|Chile|China|Colombia|Czech Republic|Denmark|Finland|Greece|India|Italy|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Sweden|Turkey|Ukraine | 1 |
| United States|Argentina|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|El Salvador|France|Germany|Guatemala|Hungary|India|Israel|Kenya|Korea, Republic of|Lebanon|Malaysia|Netherlands|Norway|Panama|Portugal|Russian Federation|Serbia|Singapore|Slovenia|Spain|Taiwan|Thailand|Turkey|Ukraine | 1 |
| United States|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam | 1 |
| United States|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|Finland|Germany|Hungary|India|Italy|Netherlands|New Zealand|Norway|Poland|South Africa|Spain|Sweden | 1 |
| United States|Australia|Austria|Belgium|Canada|Czech Republic|Estonia|Germany|Italy|Korea, Republic of|Latvia|Lithuania|Netherlands|New Zealand|Poland|Russian Federation|Singapore|South Africa|Sweden|Switzerland|Thailand | 1 |
| United States|Australia|Austria|Brazil|Canada|Colombia|Czech Republic|India|Israel|Italy|Korea, Republic of|Mexico|Poland|South Africa|Turkey | 1 |
| United States|Australia|Austria|Brazil|Canada|Hungary|Israel|Italy|Japan|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom | 1 |
| United States|Australia|Austria|Canada|Germany|Israel|Portugal|Russian Federation|Spain|Ukraine|United Kingdom | 1 |
| United States|Australia|Belgium|Canada|France|India|Switzerland | 1 |
| United States|Australia|Brazil|Bulgaria|Canada|China|Czech Republic|Denmark|France|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| United States|Australia|Brazil|Canada|China|Colombia|Denmark|Estonia|India|Indonesia|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Norway|Peru|Portugal|South Africa|Sweden|Taiwan|United Kingdom | 1 |
| United States|Australia|Brazil|Canada|Czech Republic|Denmark|France|Israel|Italy|Netherlands|Poland|South Africa|Sweden | 1 |
| United States|Australia|Brazil|Canada|India|Israel|Latvia|Lithuania|Poland|Russian Federation|South Africa|Ukraine|United Kingdom | 1 |
| United States|Australia|Canada|Italy | 1 |
| United States|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Lithuania|Mexico|Norway|Russian Federation|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine | 1 |
| United States|Belarus|Canada|Chile|China|Colombia|Egypt|India|Korea, Republic of|Lithuania|Mexico|Peru|Russian Federation|South Africa|Turkey|Ukraine | 1 |
| United States|Belgium|France|Hungary|Italy|Netherlands | 1 |
| United States|Bulgaria|Canada|Denmark|India|Israel|Lithuania|Mexico|Norway|Pakistan|Poland|Sri Lanka|Sweden | 1 |
| United States|Canada|France|India|Italy|Jordan|Lebanon|Spain|Turkey|United Kingdom | 1 |
| United States|Canada|Mexico|United Kingdom | 1 |
| United States|Norway|Russian Federation|Slovenia|Spain | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 88 |
| 2 | 13 |
| 3 | 6 |
| 4 | 5 |
| 5 | 5 |
| 6 | 2 |
| 7 | 3 |
| 8 | 3 |
| 9 | 3 |
| 10 | 4 |
| 11 | 1 |
| 13 | 2 |
| 14 | 5 |
| 15 | 3 |
| 16 | 3 |
| 17 | 2 |
| 18 | 3 |
| 19 | 2 |
| 20 | 1 |
| 21 | 4 |
| 22 | 1 |
| 23 | 1 |
| 25 | 1 |
| 26 | 1 |
| 27 | 1 |
| 29 | 1 |
| 30 | 1 |
| 31 | 2 |
| 33 | 1 |
| 35 | 1 |
| 36 | 1 |
| 37 | 1 |
| 38 | 1 |
| 39 | 1 |
| 41 | 1 |
| 54 | 2 |
| 56 | 1 |
| 59 | 1 |
| 61 | 1 |
| 62 | 2 |
| 64 | 1 |
| 65 | 1 |
| 78 | 1 |
| 94 | 1 |
| 101 | 1 |
| 108 | 1 |
| 109 | 1 |
| 116 | 1 |
| 124 | 1 |
| 126 | 1 |
| 127 | 1 |
| 135 | 1 |
| 139 | 1 |
| 143 | 1 |
| 147 | 1 |
| 151 | 1 |
| 156 | 1 |
| 158 | 1 |
| 215 | 1 |
| 220 | 1 |
| 250 | 1 |
| 267 | 1 |
| 270 | 1 |
| 322 | 1 |
| 411 | 1 |
| 454 | 1 |
| 463 | 1 |
| 676 | 1 |
| Phase | Study_Count |
|---|---|
| Phase 3 | 74 |
| Phase 2 | 40 |
| N/A | 38 |
| Phase 4 | 35 |
| Phase 1 | 11 |
| Phase 2/Phase 3 | 7 |
| Early Phase 1 | 3 |
| Phase 1/Phase 2 | 1 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 35 |
| 2 | 118 |
| 3 | 16 |
| 4 | 10 |
| 5 | 4 |
| 6 | 7 |
| 7 | 1 |
| 8 | 2 |
| 10 | 1 |
| NA | 15 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 20 | 21.00 | 8.00000 | 102 | 8.0 | 11.0000 | 20.000 | 10.0000 |
| 1st Qu. | 20 | 130.00 | 13.00000 | 102 | 108.5 | 77.5000 | 243.000 | 81.7500 |
| Median | 20 | 384.50 | 23.00000 | 102 | 276.5 | 369.0000 | 621.000 | 263.0000 |
| Mean | 52 | 39505.86 | 46.27273 | 102 | 367.6 | 603.8571 | 1376.205 | 832.2353 |
| 3rd Qu. | 68 | 1790.75 | 76.00000 | 102 | 528.0 | 850.0000 | 2055.000 | 927.5000 |
| Max. | 116 | 1260576.00 | 118.00000 | 102 | 1973.0 | 1992.0000 | 8292.000 | 5000.0000 |
| group_type | Group_Count |
|---|---|
| Experimental | 255 |
| Active Comparator | 134 |
| No Intervention | 29 |
| Placebo Comparator | 23 |
| NA | 15 |
| Other | 13 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 154 |
| Single Group Assignment | 41 |
| Crossover Assignment | 8 |
| Factorial Assignment | 2 |
| Sequential Assignment | 2 |
| NA | 2 |
| primary_purpose | Study_Count |
|---|---|
| Prevention | 114 |
| Treatment | 60 |
| Diagnostic | 7 |
| Health Services Research | 7 |
| Other | 7 |
| NA | 7 |
| Basic Science | 4 |
| Supportive Care | 2 |
| Screening | 1 |
| Country | Study_Count |
|---|---|
| NA | 24 |
| France | 17 |
| United States | 17 |
| Germany | 9 |
| Italy | 5 |
| Korea, Republic of | 5 |
| Sweden | 4 |
| Switzerland | 4 |
| Canada | 3 |
| Denmark | 3 |
| Australia | 2 |
| China | 2 |
| Netherlands | 2 |
| Norway | 2 |
| Spain | 2 |
| Algeria|Egypt|Indonesia|Jordan|Kazakhstan|Kenya|Korea, Republic of|Kuwait|Lebanon|Malaysia|Mexico|Morocco|Philippines|Qatar|Russian Federation|Saudi Arabia|Singapore|Taiwan|Turkey|Ukraine|United Arab Emirates | 1 |
| Argentina | 1 |
| Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Cyprus|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Italy|Korea, Republic of|Latvia|Lebanon|Lithuania|Macedonia, The Former Yugoslav Republic of|Mexico|Netherlands|Norway|Philippines|Portugal|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|United Arab Emirates|United Kingdom|Venezuela|Vietnam | 1 |
| Australia|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom | 1 |
| Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Moldova, Republic of|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom | 1 |
| Belgium|Canada|Germany|Italy|Netherlands|Spain | 1 |
| Canada|Netherlands|Switzerland | 1 |
| Greece | 1 |
| Ireland | 1 |
| Japan | 1 |
| Korea, Republic of|Taiwan | 1 |
| Norway|Sweden | 1 |
| Portugal | 1 |
| Russian Federation | 1 |
| Taiwan | 1 |
| United Kingdom | 1 |
| United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Czechia|Egypt|Germany|Greece|Hungary|Italy|Korea, Republic of|Latvia|Lebanon|Malaysia|Mexico|Netherlands|New Zealand|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Slovenia|Thailand|Turkey|United Arab Emirates|United Kingdom|Vietnam | 1 |
| United States|Belgium|France|Italy|Spain | 1 |
| United States|Canada | 1 |
| United States|Canada|China | 1 |
| United States|Canada|France|Italy|Spain | 1 |
| United States|Canada|United Kingdom | 1 |
| United States|Spain | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 89 |
| 2 | 5 |
| 3 | 5 |
| 4 | 1 |
| 5 | 2 |
| 6 | 2 |
| 7 | 2 |
| 8 | 1 |
| 9 | 3 |
| 10 | 1 |
| 12 | 1 |
| 14 | 1 |
| 18 | 1 |
| 19 | 1 |
| 20 | 1 |
| 21 | 2 |
| 23 | 2 |
| 42 | 1 |
| 49 | 1 |
| 53 | 1 |
| 222 | 1 |
| Measure | Observational |
|---|---|
| Min | 5.00 |
| 1st Qu | 207.50 |
| Median | 722.50 |
| Mean | 14804.15 |
| 3rd Qu | 3101.25 |
| Max | 598682.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 87 |
| NA | 11 |
| Case Control | 10 |
| Case-Only | 9 |
| Case-Control | 4 |
| Other | 2 |
| Family-Based | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 78 |
| Retrospective | 33 |
| Cross-Sectional | 6 |
| NA | 6 |
| Other | 1 |
| Country | Study_Count |
|---|---|
| United States | 3 |
| NA | 2 |
| Spain | 2 |
| Austria | 1 |
| Canada | 1 |
| China | 1 |
| Israel | 1 |
| Italy | 1 |
| Korea, Republic of | 1 |
| Russian Federation | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 12 |
| 3 | 1 |
| 10 | 1 |
| Measure | Registries |
|---|---|
| Min | 29.00 |
| 1st Qu | 402.75 |
| Median | 1098.50 |
| Mean | 73499.14 |
| 3rd Qu | 8750.00 |
| Max | 902891.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 10 |
| Case-Only | 2 |
| Other | 2 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 13 |
| Other | 1 |
| target_duration | Study_Count |
|---|---|
| 3 Years | 3 |
| 2 Years | 2 |
| 1 Day | 1 |
| 1 Year | 1 |
| 10 Months | 1 |
| 12 Months | 1 |
| 2 Weeks | 1 |
| 3 Months | 1 |
| 30 Days | 1 |
| 4 Weeks | 1 |
| 5 Years | 1 |
#If less then 500 trials
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04263038 | Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism | https://ClinicalTrials.gov/show/NCT04263038 | Recruiting | University Hospital Inselspital, Berne | 2024-02-29 |
| NCT03367364 | Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis | https://ClinicalTrials.gov/show/NCT03367364 | Active, not recruiting | Johns Hopkins University | 2020-12-01 |
| NCT03339349 | Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma | https://ClinicalTrials.gov/show/NCT03339349 | Completed | University of Utah | 2019-06-30 |
| NCT03297359 | WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03297359 | Recruiting | Ottawa Hospital Research Institute | 2022-12-31 |
| NCT03285438 | REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. | https://ClinicalTrials.gov/show/NCT03285438 | Recruiting | University Hospital, Brest | 2022-10-09 |
| NCT03276143 | FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT03276143 | Completed | Bayer | 2018-08-20 |
| NCT03266783 | Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03266783 | Recruiting | Ottawa Hospital Research Institute | 2023-06-30 |
| NCT03259204 | Swedish Multicenter Trial of Outpatient Prevention of Leg Clots | https://ClinicalTrials.gov/show/NCT03259204 | Recruiting | Karolinska University Hospital | 2020-12-31 |
| NCT03244020 | Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology | https://ClinicalTrials.gov/show/NCT03244020 | Enrolling by invitation | Massachusetts General Hospital | 2023-12-31 |
| NCT03243708 | Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients | https://ClinicalTrials.gov/show/NCT03243708 | Completed | The Cleveland Clinic | 2019-04-14 |
| NCT03212365 | Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery | https://ClinicalTrials.gov/show/NCT03212365 | Completed | University of Utah | 2019-06-02 |
| NCT03158792 | Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function | https://ClinicalTrials.gov/show/NCT03158792 | Completed | Lebanese American University | 2017-07-13 |
| NCT03129555 | The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) | https://ClinicalTrials.gov/show/NCT03129555 | Recruiting | Danish Heart Foundation | 2020-03-31 |
| NCT03124017 | Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients | https://ClinicalTrials.gov/show/NCT03124017 | Completed | University Hospital Inselspital, Berne | 2016-03-31 |
| NCT03090880 | Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) | https://ClinicalTrials.gov/show/NCT03090880 | Recruiting | Assistance Publique - Hôpitaux de Paris | 2020-12-31 |
| NCT03083782 | Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus | https://ClinicalTrials.gov/show/NCT03083782 | Completed | Thomas Jefferson University | 2017-06-05 |
| NCT03070834 | RIPT Feasibility Trial | https://ClinicalTrials.gov/show/NCT03070834 | Recruiting | Lawson Health Research Institute | 2020-02-16 |
| NCT03251963 | Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients | https://ClinicalTrials.gov/show/NCT03251963 | Completed | University of Utah | 2019-03-27 |
| NCT03055026 | Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. | https://ClinicalTrials.gov/show/NCT03055026 | Recruiting | Fadoi Foundation, Italy | 2020-12-31 |
| NCT03044574 | Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03044574 | Completed | Pirogov Russian National Research Medical University | 2018-09-30 |
| NCT02978950 | SToP: Venous Thromboembolism Screening in the Trauma Population | https://ClinicalTrials.gov/show/NCT02978950 | Recruiting | Intermountain Health Care, Inc. | 2019-12-31 |
| NCT02970032 | Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin | https://ClinicalTrials.gov/show/NCT02970032 | Completed | University of Utah | 2017-09-10 |
| NCT02969343 | Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered | https://ClinicalTrials.gov/show/NCT02969343 | Completed | Brigham and Women’s Hospital | 2018-12-31 |
| NCT02958969 | Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma | https://ClinicalTrials.gov/show/NCT02958969 | Completed | Dana-Farber Cancer Institute | 2019-06-30 |
| NCT02945280 | Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis | https://ClinicalTrials.gov/show/NCT02945280 | Recruiting | Intermountain Health Care, Inc. | 2023-12-31 |
| NCT02935530 | Thromboprophylaxis After Surgery for Gynecologic Malignancy in China | https://ClinicalTrials.gov/show/NCT02935530 | Completed | Huazhong University of Science and Technology | 2017-08-31 |
| NCT02912234 | Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants | https://ClinicalTrials.gov/show/NCT02912234 | Completed | Bristol-Myers Squibb | 2016-10-31 |
| NCT02901067 | STAT-STatin and Aspirin in Trauma | https://ClinicalTrials.gov/show/NCT02901067 | Recruiting | Denver Health and Hospital Authority | 2021-12-31 |
| NCT02870296 | Anticoagulation Medical Home | https://ClinicalTrials.gov/show/NCT02870296 | Completed | University of Massachusetts, Worcester | 2017-11-03 |
| NCT02864537 | Self-management of Anticoagulation Treatment | https://ClinicalTrials.gov/show/NCT02864537 | Completed | University of Bergen | 2013-03-31 |
| NCT02853188 | Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung | https://ClinicalTrials.gov/show/NCT02853188 | Completed | Hopital Foch | 2018-12-20 |
| NCT02832947 | PK of Rivaroxaban in Bariatric Patients - Extension | https://ClinicalTrials.gov/show/NCT02832947 | Completed | University Hospital Inselspital, Berne | 2016-06-30 |
| NCT02829957 | RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding | https://ClinicalTrials.gov/show/NCT02829957 | Recruiting | Indiana University | 2025-12-31 |
| NCT02798471 | Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) | https://ClinicalTrials.gov/show/NCT02798471 | Recruiting | Daiichi Sankyo, Inc. | 2020-12-31 |
| NCT02795065 | Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients | https://ClinicalTrials.gov/show/NCT02795065 | Completed | Al Mouwasat Hospital | 2016-03-31 |
| NCT02774265 | A Different Approach to Preventing Thrombosis | https://ClinicalTrials.gov/show/NCT02774265 | Completed | University of Maryland, Baltimore | 2017-05-31 |
| NCT02746185 | Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban | https://ClinicalTrials.gov/show/NCT02746185 | Completed | Assistance Publique - Hôpitaux de Paris | 2018-04-25 |
| NCT02744092 | Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | https://ClinicalTrials.gov/show/NCT02744092 | Active, not recruiting | Alliance Foundation Trials, LLC. | 2020-06-30 |
| NCT02704052 | Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose | https://ClinicalTrials.gov/show/NCT02704052 | Completed | University of Utah | 2018-07-31 |
| NCT02687204 | Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients | https://ClinicalTrials.gov/show/NCT02687204 | Completed | University of Utah | 2017-06-23 |
| NCT02679664 | StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study | https://ClinicalTrials.gov/show/NCT02679664 | Active, not recruiting | Ottawa Hospital Research Institute | 2020-01-13 |
| NCT02664155 | Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants | https://ClinicalTrials.gov/show/NCT02664155 | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 2020-12-31 |
| NCT02616991 | Computed Tomography CT Venography During Postpartum Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02616991 | Recruiting | Assistance Publique - Hôpitaux de Paris | 2020-03-31 |
| NCT02585713 | Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02585713 | Completed | Academic and Community Cancer Research United | 2018-04-02 |
| NCT02583191 | Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients | https://ClinicalTrials.gov/show/NCT02583191 | Recruiting | AIO-Studien-gGmbH | 2019-12-31 |
| NCT01895777 | Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) | https://ClinicalTrials.gov/show/NCT01895777 | Completed | Boehringer Ingelheim | 2019-10-16 |
| NCT02559856 | Comparison of Bleeding Risk Between Rivaroxaban and Apixaban | https://ClinicalTrials.gov/show/NCT02559856 | Completed | Ottawa Hospital Research Institute | 2017-11-30 |
| NCT02555878 | A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants | https://ClinicalTrials.gov/show/NCT02555878 | Completed | Janssen Research & Development, LLC | 2018-08-24 |
| NCT02486666 | Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose | https://ClinicalTrials.gov/show/NCT02486666 | Recruiting | Hamilton Health Sciences Corporation | 2020-12-31 |
| NCT02474212 | : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery | https://ClinicalTrials.gov/show/NCT02474212 | Recruiting | Tampere University Hospital | 2020-12-31 |
| NCT02464969 | Apixaban for the Acute Treatment of Venous Thromboembolism in Children | https://ClinicalTrials.gov/show/NCT02464969 | Recruiting | Pfizer | 2023-04-30 |
| NCT02438098 | Rivaroxaban in Bariatric Surgery | https://ClinicalTrials.gov/show/NCT02438098 | Completed | University Hospital Inselspital, Berne | 2015-11-30 |
| NCT02412982 | Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients | https://ClinicalTrials.gov/show/NCT02412982 | Recruiting | University of Cincinnati | 2018-12-31 |
| NCT02411292 | Enoxaparin Metabolism in Reconstructive Surgery Patients | https://ClinicalTrials.gov/show/NCT02411292 | Completed | University of Utah | 2016-03-31 |
| NCT02402881 | Education Bundle to Decrease Patient Refusal of VTE Prophylaxis | https://ClinicalTrials.gov/show/NCT02402881 | Completed | Johns Hopkins University | 2018-11-30 |
| NCT02379806 | The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study | https://ClinicalTrials.gov/show/NCT02379806 | Recruiting | University Hospital, Brest | 2022-12-31 |
| NCT02366871 | Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy | https://ClinicalTrials.gov/show/NCT02366871 | Completed | University of Colorado, Denver | 2019-06-30 |
| NCT02334007 | Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery | https://ClinicalTrials.gov/show/NCT02334007 | Completed | McMaster University | 2018-09-30 |
| NCT02309411 | EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis | https://ClinicalTrials.gov/show/NCT02309411 | Completed | Bayer | 2017-04-05 |
| NCT02301793 | Educating Nurses About Venous Thromboembolism (VTE) Prevention | https://ClinicalTrials.gov/show/NCT02301793 | Completed | Johns Hopkins University | 2015-03-31 |
| NCT02271399 | Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT02271399 | Completed | Hanyang University Seoul Hospital | 2016-01-31 |
| NCT02234843 | EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis | https://ClinicalTrials.gov/show/NCT02234843 | Completed | Bayer | 2019-01-30 |
| NCT02223260 | Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age | https://ClinicalTrials.gov/show/NCT02223260 | Completed | Boehringer Ingelheim | 2016-01-31 |
| NCT02197416 | Safety of Dabigatran Etexilate in Blood Clot Prevention in Children | https://ClinicalTrials.gov/show/NCT02197416 | Completed | Boehringer Ingelheim | 2019-10-16 |
| NCT02186223 | The Angel® Catheter Pivotal Clinical Trial | https://ClinicalTrials.gov/show/NCT02186223 | Completed | BiO2 Medical | 2015-12-31 |
| NCT02170935 | Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT02170935 | Completed | Boehringer Ingelheim | 2002-06-30 |
| NCT02170701 | BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT02170701 | Completed | Boehringer Ingelheim | 2001-06-30 |
| NCT02095509 | Pharmacokinetics of Enoxaparin in Intensive Care Patients | https://ClinicalTrials.gov/show/NCT02095509 | Completed | Tampere University Hospital | 2016-06-30 |
| NCT02073682 | Cancer Venous Thromboembolism (VTE) | https://ClinicalTrials.gov/show/NCT02073682 | Completed | Daiichi Sankyo, Inc. | 2017-09-15 |
| NCT02070237 | Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis | https://ClinicalTrials.gov/show/NCT02070237 | Completed | MemorialCare Health System | 2014-03-31 |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | https://ClinicalTrials.gov/show/NCT02064439 | Completed | Bayer | 2016-09-22 |
| NCT01317160 | Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture | https://ClinicalTrials.gov/show/NCT01317160 | Completed | Karolinska University Hospital | 2015-08-31 |
| NCT01308528 | Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery | https://ClinicalTrials.gov/show/NCT01308528 | Completed | Cristália Produtos QuÃmicos Farmacêuticos Ltda. | 2017-02-28 |
| NCT01304108 | Improving Venous Thromboembolism Prophylaxis | https://ClinicalTrials.gov/show/NCT01304108 | Completed | Mayo Clinic | 2010-05-31 |
| NCT01274637 | PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot | https://ClinicalTrials.gov/show/NCT01274637 | Completed | Ottawa Hospital Research Institute | 2014-01-31 |
| NCT02048865 | Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients | https://ClinicalTrials.gov/show/NCT02048865 | Completed | Ottawa Hospital Research Institute | 2018-10-10 |
| NCT01989845 | Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer | https://ClinicalTrials.gov/show/NCT01989845 | Completed | Seoul National University Hospital | 2016-12-31 |
| NCT01976988 | Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery | https://ClinicalTrials.gov/show/NCT01976988 | Completed | Cedars-Sinai Medical Center | 2015-05-31 |
| NCT01869075 | Toronto Thromboprophylaxis Patient Safety Initiative | https://ClinicalTrials.gov/show/NCT01869075 | Completed | Sunnybrook Health Sciences Centre | 2009-03-31 |
| NCT01857583 | Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs | https://ClinicalTrials.gov/show/NCT01857583 | Completed | Daiichi Sankyo, Inc. | 2012-12-31 |
| NCT01835990 | Feasibility Study of Geko vs. IPCs in Trauma | https://ClinicalTrials.gov/show/NCT01835990 | Completed | Hamilton Health Sciences Corporation | 2014-08-31 |
| NCT01720108 | Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT01720108 | Completed | Nova Scotia Health Authority | 2016-07-31 |
| NCT01713361 | Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT01713361 | Completed | Ionis Pharmaceuticals, Inc. | 2014-05-31 |
| NCT01653405 | Improving Anticoagulation Control in VISN 1 | https://ClinicalTrials.gov/show/NCT01653405 | Completed | VA Office of Research and Development | 2016-09-30 |
| NCT01598805 | Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts | https://ClinicalTrials.gov/show/NCT01598805 | Completed | University of Zurich | 2012-09-30 |
| NCT01583218 | Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) | https://ClinicalTrials.gov/show/NCT01583218 | Completed | Portola Pharmaceuticals | 2015-12-31 |
| NCT01573169 | PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients | https://ClinicalTrials.gov/show/NCT01573169 | Recruiting | University Of Perugia | 2020-12-31 |
| NCT01561885 | Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways | https://ClinicalTrials.gov/show/NCT01561885 | Completed | King Abdullah International Medical Research Center | 2016-03-31 |
| NCT01524653 | Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) | https://ClinicalTrials.gov/show/NCT01524653 | Completed | University of Vermont | 2016-07-01 |
| NCT01467583 | Fondaparinux in Critically Ill Patients With Renal Failure | https://ClinicalTrials.gov/show/NCT01467583 | Completed | Wayne State University | 2013-11-30 |
| NCT01431456 | Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery | https://ClinicalTrials.gov/show/NCT01431456 | Completed | Martini Hospital Groningen | 2014-10-31 |
| NCT01403090 | Safety Study of the Angelâ„¢ Catheter in Subjects With Risk of Pulmonary Embolism | https://ClinicalTrials.gov/show/NCT01403090 | Completed | BiO2 Medical | 2012-03-31 |
| NCT01401725 | Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients | https://ClinicalTrials.gov/show/NCT01401725 | Completed | McMaster University | 2012-06-30 |
| NCT01348074 | Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist | https://ClinicalTrials.gov/show/NCT01348074 | Completed | McMaster University | 2013-12-31 |
| NCT04444700 | A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04444700 | Recruiting | University of Sao Paulo General Hospital | 2020-10-31 |
| NCT04393909 | Improving Safety of Diagnosis and Therapy in the Inpatient Setting | https://ClinicalTrials.gov/show/NCT04393909 | Recruiting | Brigham and Women’s Hospital | 2021-06-30 |
| NCT04267718 | Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients | https://ClinicalTrials.gov/show/NCT04267718 | Recruiting | Fadoi Foundation, Italy | 2020-04-30 |
| NCT04169269 | Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban | https://ClinicalTrials.gov/show/NCT04169269 | Recruiting | Florida Orthopaedic Institute | 2020-12-31 |
| NCT04157881 | A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04157881 | Recruiting | Population Health Research Institute | 2020-04-30 |
| NCT04141254 | Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. | https://ClinicalTrials.gov/show/NCT04141254 | Recruiting | University Hospital, Brest | 2021-12-31 |
| NCT04072068 | Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy | https://ClinicalTrials.gov/show/NCT04072068 | Recruiting | Gruppo Oncologico Italiano di Ricerca Clinica | 2020-07-31 |
| NCT04066764 | Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters | https://ClinicalTrials.gov/show/NCT04066764 | Recruiting | Second Affiliated Hospital, School of Medicine, Zhejiang University | 2024-10-01 |
| NCT04041843 | Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT04041843 | Recruiting | New York Medical College | 2020-05-31 |
| NCT04022915 | PET Fibrin Imaging of DVT and PE | https://ClinicalTrials.gov/show/NCT04022915 | Recruiting | Massachusetts General Hospital | 2023-05-13 |
| NCT03988101 | Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event | https://ClinicalTrials.gov/show/NCT03988101 | Recruiting | Yonsei University | 2021-02-28 |
| NCT03919890 | A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers | https://ClinicalTrials.gov/show/NCT03919890 | Completed | Ono Pharmaceutical Co. Ltd | 2019-08-23 |
| NCT03812328 | Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement | https://ClinicalTrials.gov/show/NCT03812328 | Completed | Tetherex Pharmaceuticals Corporation | 2019-10-01 |
| NCT03728166 | Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) | https://ClinicalTrials.gov/show/NCT03728166 | Recruiting | Brigham and Women’s Hospital | 2020-11-30 |
| NCT03691753 | Safety and Efficacy Study of Fitaya Vena Cava Filter | https://ClinicalTrials.gov/show/NCT03691753 | Recruiting | Lifetech Scientific (Shenzhen) Co., Ltd. | 2020-04-30 |
| NCT03678506 | Apixaban for Extended Anticoagulation (APIDULCIS) | https://ClinicalTrials.gov/show/NCT03678506 | Recruiting | Arianna Anticoagulazione Foundation | 2021-02-28 |
| NCT03559114 | PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) | https://ClinicalTrials.gov/show/NCT03559114 | Recruiting | Sunnybrook Health Sciences Centre | 2022-12-31 |
| NCT03522259 | Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery | https://ClinicalTrials.gov/show/NCT03522259 | Recruiting | University Hospital Inselspital, Berne | 2021-12-31 |
| NCT03516656 | Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin | https://ClinicalTrials.gov/show/NCT03516656 | Active, not recruiting | University of Utah | 2019-06-30 |
| NCT03424460 | Venous Thromboembolism in Myotonic Dystrophy Type 1 | https://ClinicalTrials.gov/show/NCT03424460 | Recruiting | Assistance Publique - Hôpitaux de Paris | 2021-01-11 |
| NCT01267305 | The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery | https://ClinicalTrials.gov/show/NCT01267305 | Completed | Shanghai Zhongshan Hospital | 2013-04-30 |
| NCT01234064 | Graduated Compression Stockings (GCS) Pilot Substudy | https://ClinicalTrials.gov/show/NCT01234064 | Completed | McMaster University | 2011-12-31 |
| NCT01225822 | BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery | https://ClinicalTrials.gov/show/NCT01225822 | Completed | Boehringer Ingelheim | 2003-08-31 |
| NCT01210755 | Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics | https://ClinicalTrials.gov/show/NCT01210755 | Completed | University Hospital, Grenoble | 2011-03-31 |
| NCT01206972 | Dose-confirmatory Bridging Study in Total Knee Replacement | https://ClinicalTrials.gov/show/NCT01206972 | Completed | Bayer | 2011-05-31 |
| NCT01205932 | Dose-confirmatory Bridging Study in Total Hip Replacement | https://ClinicalTrials.gov/show/NCT01205932 | Completed | Bayer | 2011-06-30 |
| NCT01203098 | A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty | https://ClinicalTrials.gov/show/NCT01203098 | Completed | Daiichi Sankyo, Inc. | 2008-12-31 |
| NCT01203072 | A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT01203072 | Completed | Daiichi Sankyo, Inc. | 2007-09-30 |
| NCT01184989 | Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate | https://ClinicalTrials.gov/show/NCT01184989 | Completed | Boehringer Ingelheim | 2013-04-30 |
| NCT01181167 | A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty | https://ClinicalTrials.gov/show/NCT01181167 | Completed | Daiichi Sankyo, Inc. | 2010-01-31 |
| NCT01181141 | Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery | https://ClinicalTrials.gov/show/NCT01181141 | Completed | Daiichi Sankyo, Inc. | 2009-08-31 |
| NCT01181102 | A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT01181102 | Completed | Daiichi Sankyo, Inc. | 2009-09-30 |
| NCT01130025 | Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | https://ClinicalTrials.gov/show/NCT01130025 | Completed | LEO Pharma | 2014-04-30 |
| NCT01119300 | EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin | https://ClinicalTrials.gov/show/NCT01119300 | Completed | Utrecht Institute for Pharmaceutical Sciences | 2013-10-31 |
| NCT01119274 | EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon | https://ClinicalTrials.gov/show/NCT01119274 | Completed | Utrecht Institute for Pharmaceutical Sciences | 2013-01-31 |
| NCT01119261 | EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol | https://ClinicalTrials.gov/show/NCT01119261 | Completed | Utrecht Institute for Pharmaceutical Sciences | 2013-06-30 |
| NCT01083732 | Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age | https://ClinicalTrials.gov/show/NCT01083732 | Completed | Boehringer Ingelheim | 2016-02-29 |
| NCT01050153 | The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma | https://ClinicalTrials.gov/show/NCT01050153 | Completed | Denver Health and Hospital Authority | 2011-12-31 |
| NCT01028950 | YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness | https://ClinicalTrials.gov/show/NCT01028950 | Completed | Astellas Pharma Inc | 2010-04-30 |
| NCT00986154 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | https://ClinicalTrials.gov/show/NCT00986154 | Completed | Daiichi Sankyo, Inc. | 2013-04-30 |
| NCT00978445 | Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System | https://ClinicalTrials.gov/show/NCT00978445 | Completed | ZIN Technologies, Inc. | 2010-08-31 |
| NCT00967304 | Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00967304 | Completed | Ottawa Hospital Research Institute | 2015-01-31 |
| NCT00966277 | Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | https://ClinicalTrials.gov/show/NCT00966277 | Completed | M.D. Anderson Cancer Center | 2014-09-30 |
| NCT00952380 | Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients | https://ClinicalTrials.gov/show/NCT00952380 | Completed | Pfizer | 2018-03-31 |
| NCT00942435 | A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery | https://ClinicalTrials.gov/show/NCT00942435 | Completed | Astellas Pharma Inc | 2010-04-30 |
| NCT00937911 | Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities | https://ClinicalTrials.gov/show/NCT00937911 | Completed | Astellas Pharma Inc | 2010-04-30 |
| NCT00937820 | Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00937820 | Completed | Astellas Pharma Inc | 2010-12-31 |
| NCT00917254 | Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery | https://ClinicalTrials.gov/show/NCT00917254 | Completed | Astellas Pharma Inc | 2010-01-31 |
| NCT00913120 | Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT00913120 | Completed | Astellas Pharma Inc | 2010-03-31 |
| NCT00902928 | A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT00902928 | Completed | Astellas Pharma Inc | 2010-06-30 |
| NCT00878826 | Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. | https://ClinicalTrials.gov/show/NCT00878826 | Completed | Stanford University | 2011-08-31 |
| NCT00853463 | Discharge ALERT: Quality Improvement Initiative | https://ClinicalTrials.gov/show/NCT00853463 | Completed | Brigham and Women’s Hospital | 2010-03-31 |
| NCT00851864 | Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing | https://ClinicalTrials.gov/show/NCT00851864 | Completed | University of Calgary | 2010-10-31 |
| NCT00844415 | Safety and Tolerability of Dabigatran Etexilate in Adolescents | https://ClinicalTrials.gov/show/NCT00844415 | Completed | Boehringer Ingelheim | 2012-02-29 |
| NCT03240120 | A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03240120 | Recruiting | The University of Hong Kong | 2021-05-31 |
| NCT03045406 | Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer | https://ClinicalTrials.gov/show/NCT03045406 | Active, not recruiting | Fadoi Foundation, Italy | 2019-06-01 |
| NCT02303431 | Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study | https://ClinicalTrials.gov/show/NCT02303431 | Recruiting | Daiichi Sankyo, Inc. | 2020-09-30 |
| NCT00814177 | Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients | https://ClinicalTrials.gov/show/NCT00814177 | Completed | McMaster University | 2009-01-31 |
| NCT04257487 | Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) | https://ClinicalTrials.gov/show/NCT04257487 | Recruiting | Arianna Anticoagulazione Foundation | 2023-09-02 |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03139487 | Recruiting | Asan Medical Center | 2021-09-30 |
| NCT04373707 | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 | https://ClinicalTrials.gov/show/NCT04373707 | Recruiting | Central Hospital, Nancy, France | 2020-09-30 |
| NCT00790335 | Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis | https://ClinicalTrials.gov/show/NCT00790335 | Completed | Washington University School of Medicine | 2017-01-31 |
| NCT00774748 | Once Weekly Subcutaneous Ports for the Administration of Anticoagulants | https://ClinicalTrials.gov/show/NCT00774748 | Completed | University of North Carolina, Chapel Hill | 2010-04-30 |
| NCT00773448 | Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00773448 | Completed | Ottawa Hospital Research Institute | 2015-04-30 |
| NCT00740987 | Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) | https://ClinicalTrials.gov/show/NCT00740987 | Completed | University Hospital, Brest | 2015-01-31 |
| NCT00740844 | Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk | https://ClinicalTrials.gov/show/NCT00740844 | Completed | University Hospital, Brest | 2011-01-31 |
| NCT00740493 | Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) | https://ClinicalTrials.gov/show/NCT00740493 | Completed | University Hospital, Brest | 2017-01-31 |
| NCT00723216 | Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery | https://ClinicalTrials.gov/show/NCT00723216 | Completed | Sanofi | 2007-12-31 |
| NCT00721760 | Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery | https://ClinicalTrials.gov/show/NCT00721760 | Completed | Sanofi | 2009-10-31 |
| NCT00718224 | Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery | https://ClinicalTrials.gov/show/NCT00718224 | Completed | Sanofi | 2009-05-31 |
| NCT00709904 | Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery | https://ClinicalTrials.gov/show/NCT00709904 | Completed | Sanofi | 2010-01-31 |
| NCT00697099 | Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT00697099 | Completed | Sanofi | 2009-06-30 |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy | https://ClinicalTrials.gov/show/NCT00694382 | Completed | Sanofi | 2010-11-30 |
| NCT00689520 | Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis | https://ClinicalTrials.gov/show/NCT00689520 | Completed | Hospital Universitari de Bellvitge | 2005-01-31 |
| NCT00680186 | Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) | https://ClinicalTrials.gov/show/NCT00680186 | Completed | Boehringer Ingelheim | 2011-05-31 |
| NCT00679588 | Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery | https://ClinicalTrials.gov/show/NCT00679588 | Completed | Sanofi | 2010-08-31 |
| NCT00657150 | Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty | https://ClinicalTrials.gov/show/NCT00657150 | Completed | Boehringer Ingelheim | 2009-09-30 |
| NCT00641732 | Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement | https://ClinicalTrials.gov/show/NCT00641732 | Completed | Takeda | 2008-10-31 |
| NCT00634907 | Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) | https://ClinicalTrials.gov/show/NCT00634907 | Completed | University of Utah | 2008-10-31 |
| NCT00629447 | Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients | https://ClinicalTrials.gov/show/NCT00629447 | Completed | Duke University | 2007-03-31 |
| NCT00571649 | Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients | https://ClinicalTrials.gov/show/NCT00571649 | Completed | Bayer | 2010-08-31 |
| NCT00558259 | Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE | https://ClinicalTrials.gov/show/NCT00558259 | Completed | Boehringer Ingelheim | 2011-02-28 |
| NCT00531843 | The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients | https://ClinicalTrials.gov/show/NCT00531843 | Completed | University of California, San Francisco | 2008-06-30 |
| NCT00476216 | Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer | https://ClinicalTrials.gov/show/NCT00476216 | Completed | University of Alabama at Birmingham | 2012-12-31 |
| NCT00470626 | Celect Vena Cava Filter Clinical Trial | https://ClinicalTrials.gov/show/NCT00470626 | Completed | Cook Group Incorporated | 2009-03-31 |
| NCT00439725 | Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study | https://ClinicalTrials.gov/show/NCT00439725 | Completed | Bayer | 2009-08-31 |
| NCT00408239 | Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement | https://ClinicalTrials.gov/show/NCT00408239 | Completed | Astellas Pharma Inc | 2009-03-31 |
| NCT00402467 | An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study | https://ClinicalTrials.gov/show/NCT00402467 | Completed | Bayer | 2004-11-30 |
| NCT00398905 | Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | https://ClinicalTrials.gov/show/NCT00398905 | Completed | Bayer | NA |
| NCT00396786 | Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | https://ClinicalTrials.gov/show/NCT00396786 | Completed | Bayer | 2005-07-31 |
| NCT00395772 | Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis | https://ClinicalTrials.gov/show/NCT00395772 | Completed | Bayer | NA |
| NCT00362232 | Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. | https://ClinicalTrials.gov/show/NCT00362232 | Completed | Bayer | 2007-01-31 |
| NCT00361894 | Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. | https://ClinicalTrials.gov/show/NCT00361894 | Completed | Bayer | 2007-01-31 |
| NCT00361647 | Screening for Occult Malignancy in Idiopathic Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00361647 | Completed | University of Padova | 2008-05-31 |
| NCT00338897 | Dose Ranging Study in Elective Total Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT00338897 | Completed | Sanofi | 2007-05-31 |
| NCT00333021 | Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients | https://ClinicalTrials.gov/show/NCT00333021 | Completed | GlaxoSmithKline | NA |
| NCT00332020 | Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | https://ClinicalTrials.gov/show/NCT00332020 | Completed | Bayer | 2007-05-31 |
| NCT00331838 | Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery | https://ClinicalTrials.gov/show/NCT00331838 | Completed | Sanofi | 2007-06-30 |
| NCT00329628 | Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin | https://ClinicalTrials.gov/show/NCT00329628 | Completed | Bayer | 2007-03-31 |
| NCT00291330 | Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00291330 | Completed | Boehringer Ingelheim | 2009-05-31 |
| NCT00264277 | D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00264277 | Completed | St. Orsola Hospital | 2004-12-31 |
| NCT00246025 | A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. | https://ClinicalTrials.gov/show/NCT00246025 | Completed | Boehringer Ingelheim | 2007-06-30 |
| NCT00244725 | Odiparcil For The Prevention Of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00244725 | Completed | GlaxoSmithKline | 2006-09-30 |
| NCT00219973 | CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) | https://ClinicalTrials.gov/show/NCT00219973 | Completed | Rovi Pharmaceuticals Laboratories | NA |
| NCT00196118 | Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter | https://ClinicalTrials.gov/show/NCT00196118 | Completed | Cook Group Incorporated | NA |
| NCT00182403 | Fixed Dose Heparin Study | https://ClinicalTrials.gov/show/NCT00182403 | Completed | McMaster University | NA |
| NCT00182221 | Safety of a Diagnostic Strategy With D-Dimer Testing for PE | https://ClinicalTrials.gov/show/NCT00182221 | Completed | McMaster University | 2008-02-29 |
| NCT00168818 | Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery | https://ClinicalTrials.gov/show/NCT00168818 | Completed | Boehringer Ingelheim | 2006-07-31 |
| NCT00152971 | Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement | https://ClinicalTrials.gov/show/NCT00152971 | Completed | Boehringer Ingelheim | 2006-06-30 |
| NCT00135876 | Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | https://ClinicalTrials.gov/show/NCT00135876 | Completed | Ontario Clinical Oncology Group (OCOG) | NA |
| NCT00119457 | Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) | https://ClinicalTrials.gov/show/NCT00119457 | Completed | vTv Therapeutics | NA |
| NCT00077805 | PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) | https://ClinicalTrials.gov/show/NCT00077805 | Completed | Sanofi | 2006-07-31 |
| NCT00077753 | EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization | https://ClinicalTrials.gov/show/NCT00077753 | Completed | Sanofi | 2006-10-31 |
| NCT00007085 | Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) | https://ClinicalTrials.gov/show/NCT00007085 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 2004-12-31 |
| NCT00000614 | Prevention of Recurrent Venous Thromboembolism (PREVENT) | https://ClinicalTrials.gov/show/NCT00000614 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
#If less then 500 studies
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04349189 | Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait | https://ClinicalTrials.gov/show/NCT04349189 | Recruiting | National Institutes of Health Clinical Center (CC) | 2020-12-15 |
| NCT03407469 | Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization | https://ClinicalTrials.gov/show/NCT03407469 | Recruiting | M.D. Anderson Cancer Center | 2019-12-31 |
| NCT03405571 | Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias. | https://ClinicalTrials.gov/show/NCT03405571 | Recruiting | University of Athens | 2020-06-30 |
| NCT03381963 | Hemostatic Profiles of Endocrine Therapies for Breast Cancer | https://ClinicalTrials.gov/show/NCT03381963 | Completed | University Hospital, Geneva | 2020-02-28 |
| NCT03292666 | Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study | https://ClinicalTrials.gov/show/NCT03292666 | Recruiting | University of California, San Francisco | 2020-12-31 |
| NCT03282747 | Distribution of Risk Factors for Venous Thromboembolism in Blood Donors | https://ClinicalTrials.gov/show/NCT03282747 | Completed | Casa Sollievo della Sofferenza IRCCS | 2018-07-15 |
| NCT03214172 | Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban | https://ClinicalTrials.gov/show/NCT03214172 | Completed | Bayer | 2017-09-15 |
| NCT03206372 | Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure | https://ClinicalTrials.gov/show/NCT03206372 | Recruiting | University Hospital, Brest | 2020-10-24 |
| NCT03141749 | Venous Thromboembolism in DM1 | https://ClinicalTrials.gov/show/NCT03141749 | Completed | Institut de Myologie, France | 2014-11-30 |
| NCT03134820 | Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease | https://ClinicalTrials.gov/show/NCT03134820 | Completed | Delos Clinical | 2016-12-31 |
| NCT03115541 | Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection | https://ClinicalTrials.gov/show/NCT03115541 | Recruiting | McMaster University | 2019-12-30 |
| NCT03114618 | A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient | https://ClinicalTrials.gov/show/NCT03114618 | Completed | Hospital General Universitario Gregorio Marañon | 2016-11-30 |
| NCT03099031 | Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | https://ClinicalTrials.gov/show/NCT03099031 | Completed | LEO Pharma | 2017-05-15 |
| NCT03087474 | Treatment of Venous Thromboembolism in Real-Life Patients | https://ClinicalTrials.gov/show/NCT03087474 | Completed | Bristol-Myers Squibb | 2017-12-31 |
| NCT03068923 | Thrombosis Outcomes in Pediatric Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03068923 | Active, not recruiting | University of Texas Southwestern Medical Center | 2022-02-28 |
| NCT03041805 | Caprini Score in Venous Surgery: a Prospective Cohort Study | https://ClinicalTrials.gov/show/NCT03041805 | Recruiting | Pirogov Russian National Research Medical University | 2025-01-01 |
| NCT03031457 | Microsurgical Breast Reconstruction & VTE | https://ClinicalTrials.gov/show/NCT03031457 | Completed | Stanford University | 2017-12-15 |
| NCT03025100 | VTE Prophylaxis Guidelines in Hospitalized Elders | https://ClinicalTrials.gov/show/NCT03025100 | Completed | Duke University | 2017-03-04 |
| NCT02952599 | Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN) | https://ClinicalTrials.gov/show/NCT02952599 | Completed | Daiichi Sankyo, Inc. | 2019-10-29 |
| NCT02943993 | Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe | https://ClinicalTrials.gov/show/NCT02943993 | Active, not recruiting | Daiichi Sankyo, Inc. | 2020-11-30 |
| NCT02898090 | Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions | https://ClinicalTrials.gov/show/NCT02898090 | Recruiting | University Hospital, Bordeaux | 2020-04-30 |
| NCT02895971 | Incidence of Venous Thromboembolism and Professional Practices in Brest Area | https://ClinicalTrials.gov/show/NCT02895971 | Completed | University Hospital, Brest | 2017-06-30 |
| NCT02828904 | RIVET-Case Control Study | https://ClinicalTrials.gov/show/NCT02828904 | Recruiting | Center for Epidemiology and Health Research, Germany | 2021-03-31 |
| NCT02742623 | A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer | https://ClinicalTrials.gov/show/NCT02742623 | Completed | Bayer | 2018-11-30 |
| NCT02739867 | Tumor-educated Platelets in Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02739867 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-07-31 |
| NCT02661568 | Description of Patients With Acute Venous Thromboembolism in the UK’s Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES) | https://ClinicalTrials.gov/show/NCT02661568 | Completed | Bristol-Myers Squibb | 2015-12-31 |
| NCT02596230 | RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02596230 | Completed | Boehringer Ingelheim | 2019-03-31 |
| NCT03404635 | Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03404635 | Recruiting | Indiana University | 2020-12-31 |
| NCT02558465 | Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) | https://ClinicalTrials.gov/show/NCT02558465 | Active, not recruiting | Bayer | 2020-04-01 |
| NCT02552420 | The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02552420 | Completed | The First Affiliated Hospital of Guangzhou Medical University | 2012-07-31 |
| NCT02480790 | Venous Thromboembolic Complications in Ovarian Cancer | https://ClinicalTrials.gov/show/NCT02480790 | Active, not recruiting | Aalborg University Hospital | 2017-05-31 |
| NCT02443610 | Haemorrhages and Thromboembolic Venous Disease of the Postpartum | https://ClinicalTrials.gov/show/NCT02443610 | Recruiting | University Hospital, Brest | 2019-02-28 |
| NCT02407717 | Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer | https://ClinicalTrials.gov/show/NCT02407717 | Completed | G. d’Annunzio University | 2017-08-31 |
| NCT02297373 | Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) | https://ClinicalTrials.gov/show/NCT02297373 | Active, not recruiting | Ottawa Hospital Research Institute | 2019-01-03 |
| NCT02268630 | Long Term Outcomes of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02268630 | Recruiting | Ostfold Hospital Trust | 2023-10-31 |
| NCT02210819 | Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy | https://ClinicalTrials.gov/show/NCT02210819 | Completed | Bayer | 2016-11-03 |
| NCT02156401 | VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE | https://ClinicalTrials.gov/show/NCT02156401 | Recruiting | Johannes Gutenberg University Mainz | 2023-07-31 |
| NCT01297348 | Study Of Lybrel In Relation To Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT01297348 | Completed | Pfizer | 2012-04-30 |
| NCT01277536 | Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland | https://ClinicalTrials.gov/show/NCT01277536 | Completed | University Hospital, Geneva | 2011-11-30 |
| NCT02037607 | Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures | https://ClinicalTrials.gov/show/NCT02037607 | Completed | Indiana University | 2015-07-31 |
| NCT01958203 | Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines. | https://ClinicalTrials.gov/show/NCT01958203 | Completed | Ministry of Health, United Arab Emirates | 2013-08-31 |
| NCT01941602 | A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery | https://ClinicalTrials.gov/show/NCT01941602 | Completed | St. Olavs Hospital | 2015-10-31 |
| NCT01885585 | Eliquis Regulatory Post Marketing Surveillance (rPMS) | https://ClinicalTrials.gov/show/NCT01885585 | Completed | Bristol-Myers Squibb | 2015-05-31 |
| NCT01855698 | PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT01855698 | Completed | Gruppo Italiano Malattie EMatologiche dell’Adulto | 2018-03-15 |
| NCT01851239 | Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital | https://ClinicalTrials.gov/show/NCT01851239 | Completed | Yonsei University | 2013-07-31 |
| NCT01809015 | Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme | https://ClinicalTrials.gov/show/NCT01809015 | Completed | Johannes Gutenberg University Mainz | 2018-03-31 |
| NCT01803022 | Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer | https://ClinicalTrials.gov/show/NCT01803022 | Completed | LEO Pharma | 2013-07-31 |
| NCT01781858 | Study on the Clinical Course Of Pulmonary Embolism | https://ClinicalTrials.gov/show/NCT01781858 | Completed | University of Padova | 2014-05-31 |
| NCT01619007 | Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy | https://ClinicalTrials.gov/show/NCT01619007 | Completed | Bayer | 2015-03-31 |
| NCT01602445 | Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT01602445 | Completed | Ottawa Hospital Research Institute | 2016-10-31 |
| NCT01602432 | Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients | https://ClinicalTrials.gov/show/NCT01602432 | Completed | Ottawa Hospital Research Institute | 2013-08-31 |
| NCT01559207 | Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT01559207 | Completed | Centre Hospitalier Universitaire de NÄ«mes | 2014-10-31 |
| NCT01524393 | Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization | https://ClinicalTrials.gov/show/NCT01524393 | Completed | Danderyd Hospital | 2008-12-31 |
| NCT01428544 | Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) | https://ClinicalTrials.gov/show/NCT01428544 | Completed | GlaxoSmithKline | 2015-06-30 |
| NCT01428531 | Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment | https://ClinicalTrials.gov/show/NCT01428531 | Completed | GlaxoSmithKline | 2015-06-30 |
| NCT01372514 | Institutional Registry of Thromboembolic Disease | https://ClinicalTrials.gov/show/NCT01372514 | Recruiting | Hospital Italiano de Buenos Aires | 2020-01-31 |
| NCT01362933 | National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients | https://ClinicalTrials.gov/show/NCT01362933 | Completed | Floralis | 2012-01-31 |
| NCT01345773 | Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer | https://ClinicalTrials.gov/show/NCT01345773 | Completed | Seoul National University Bundang Hospital | 2011-09-30 |
| NCT04374617 | Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04374617 | Completed | Hospital Universitari Vall d’Hebron Research Institute | 2020-04-25 |
| NCT04335162 | Cardiovascular Complications and COVID-19 (CovCardioVasc) | https://ClinicalTrials.gov/show/NCT04335162 | Recruiting | Centre Hospitalier Universitaire de Nice | 2020-08-28 |
| NCT04301362 | Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | https://ClinicalTrials.gov/show/NCT04301362 | Recruiting | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 2021-07-19 |
| NCT04257305 | Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients | https://ClinicalTrials.gov/show/NCT04257305 | Completed | Huashan Hospital | 2019-12-31 |
| NCT04179487 | The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study | https://ClinicalTrials.gov/show/NCT04179487 | Recruiting | University College Dublin | 2023-12-31 |
| NCT04141228 | A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US | https://ClinicalTrials.gov/show/NCT04141228 | Completed | Bristol-Myers Squibb | 2018-04-30 |
| NCT04130048 | Thrombus Elastography in Venous Thrombo-Embolism. | https://ClinicalTrials.gov/show/NCT04130048 | Recruiting | University Hospital, Brest | 2019-12-14 |
| NCT04122430 | Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours - a Multi-Site Retrospective Cohort Study as Part of the Global Germ-Cell Cancer Group (G3) Consortium | https://ClinicalTrials.gov/show/NCT04122430 | Active, not recruiting | Walter and Eliza Hall Institute of Medical Research | 2019-12-31 |
| NCT04117217 | Risk Factors for Thrombosis in Children With Central Venous Lines | https://ClinicalTrials.gov/show/NCT04117217 | Recruiting | University of Arizona | 2023-12-31 |
| NCT03965741 | Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners | https://ClinicalTrials.gov/show/NCT03965741 | Active, not recruiting | Bayer | 2020-07-31 |
| NCT03949985 | Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives | https://ClinicalTrials.gov/show/NCT03949985 | Recruiting | University Hospital, Geneva | 2020-12-31 |
| NCT03835780 | The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study | https://ClinicalTrials.gov/show/NCT03835780 | Completed | Momentum Data | 2019-08-01 |
| NCT03802929 | Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03802929 | Recruiting | Shanghai 10th People’s Hospital | 2024-12-31 |
| NCT03799016 | An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan | https://ClinicalTrials.gov/show/NCT03799016 | Completed | Bayer | 2017-07-01 |
| NCT03781531 | Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03781531 | Recruiting | Danderyd Hospital | 2022-12-31 |
| NCT03646409 | Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer | https://ClinicalTrials.gov/show/NCT03646409 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2018-10-01 |
| NCT03535428 | Venous Thrombo-embolic Complication prévention in Pelvic Surgery | https://ClinicalTrials.gov/show/NCT03535428 | Completed | Groupe Hospitalier Paris Saint Joseph | 2018-04-25 |
| NCT03535090 | Coagulation After Intravenous Methylprednisolone Administration | https://ClinicalTrials.gov/show/NCT03535090 | Completed | Medical University of Warsaw | 2014-12-31 |
| NCT03477968 | ThRombosis ExclUsion STudy | https://ClinicalTrials.gov/show/NCT03477968 | Recruiting | Diagnostica Stago | 2020-09-30 |
| NCT03475771 | Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture Surgery | https://ClinicalTrials.gov/show/NCT03475771 | Completed | Groupe Hospitalier Paris Saint Joseph | 2017-12-31 |
| NCT01221805 | STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT01221805 | Completed | Diagnostica Stago | 2016-03-31 |
| NCT01212393 | Prevention of Venous Thromboembolism Disease in Emergency Departments | https://ClinicalTrials.gov/show/NCT01212393 | Completed | University Hospital, Angers | 2011-03-31 |
| NCT01158482 | Filter Initial & Long Term Evaluation After Placement and Retrieval Registry | https://ClinicalTrials.gov/show/NCT01158482 | Recruiting | Stanford University | 2025-06-30 |
| NCT01140386 | Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients | https://ClinicalTrials.gov/show/NCT01140386 | Completed | Penn State University | 2010-03-31 |
| NCT01139658 | Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA | https://ClinicalTrials.gov/show/NCT01139658 | Completed | Boehringer Ingelheim | 2012-09-30 |
| NCT01047618 | Venous Thromboembolism in Advanced Gastric Cancer Patients | https://ClinicalTrials.gov/show/NCT01047618 | Completed | Asan Medical Center | 2014-12-31 |
| NCT01046903 | An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin® | https://ClinicalTrials.gov/show/NCT01046903 | Completed | Pfizer | 2011-02-28 |
| NCT01029743 | Xarelto Regulatory Post-Marketing Surveillance | https://ClinicalTrials.gov/show/NCT01029743 | Completed | Bayer | 2015-03-31 |
| NCT01004939 | Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT01004939 | Completed | GlaxoSmithKline | 2010-07-31 |
| NCT00973596 | The Swiss Venous Thromboembolism Cohort 65+ | https://ClinicalTrials.gov/show/NCT00973596 | Completed | University of Lausanne Hospitals | 2012-03-31 |
| NCT00954395 | DULCIS (D-dimer and ULtrasonography in Combination Italian Study) | https://ClinicalTrials.gov/show/NCT00954395 | Completed | St. Orsola Hospital | 2011-12-31 |
| NCT00925808 | Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans | https://ClinicalTrials.gov/show/NCT00925808 | Active, not recruiting | M.D. Anderson Cancer Center | 2020-06-30 |
| NCT00856076 | Venous Thromboembolism in Pregnancy Study | https://ClinicalTrials.gov/show/NCT00856076 | Recruiting | Oslo University Hospital | 2010-12-31 |
| NCT04400877 | Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400877 | Recruiting | University Hospital, Linkoeping | 2020-06-19 |
| NCT01176305 | Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005 | https://ClinicalTrials.gov/show/NCT01176305 | Completed | Hillerod Hospital, Denmark | NA |
| NCT00831714 | Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT00831714 | Completed | Bayer | 2011-06-30 |
| NCT00830570 | The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings | https://ClinicalTrials.gov/show/NCT00830570 | Completed | Medco Health Solutions, Inc. | 2010-01-31 |
| NCT03773939 | Risk Prediction of Venous Thromboembolism in Critically Ill | https://ClinicalTrials.gov/show/NCT03773939 | Recruiting | University Medical Center Groningen | 2021-05-01 |
| NCT00810784 | Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients | https://ClinicalTrials.gov/show/NCT00810784 | Completed | University of Utah | 2007-03-31 |
| NCT02713581 | IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02713581 | Completed | Centre Hospitalier Universitaire de NÄ«mes | 2019-01-03 |
| NCT03870464 | LIFE - Lung Cancer, Immunotherapy, Frailty, Effect | https://ClinicalTrials.gov/show/NCT03870464 | Recruiting | University of Southern Denmark | 2021-09-30 |
| NCT00788736 | Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00788736 | Completed | Ottawa Hospital Research Institute | 2016-09-30 |
| NCT00755300 | Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques | https://ClinicalTrials.gov/show/NCT00755300 | Completed | University of California, Davis | 2008-06-30 |
| NCT00745212 | Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women | https://ClinicalTrials.gov/show/NCT00745212 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 2012-12-31 |
| NCT00695942 | Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease | https://ClinicalTrials.gov/show/NCT00695942 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 2012-05-31 |
| NCT00683397 | Frankfurt Thrombophilia Registry | https://ClinicalTrials.gov/show/NCT00683397 | Completed | Cardioangiologisches Centrum Bethanien | 2014-12-31 |
| NCT00676065 | Long-term Active Surveillance Study for Oral Contraceptives (LASS) | https://ClinicalTrials.gov/show/NCT00676065 | Completed | Center for Epidemiology and Health Research, Germany | 2011-03-31 |
| NCT00660205 | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | https://ClinicalTrials.gov/show/NCT00660205 | Completed | University of Aarhus | 2011-02-28 |
| NCT00631423 | Evaluation of Patients With Vena Cava Inferior Thrombosis | https://ClinicalTrials.gov/show/NCT00631423 | Completed | Johann Wolfgang Goethe University Hospital | 2014-04-30 |
| NCT00604370 | Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge | https://ClinicalTrials.gov/show/NCT00604370 | Completed | Brigham and Women’s Hospital | 2010-02-28 |
| NCT00535171 | Venous Thromboembolism Taskforce Audit Program | https://ClinicalTrials.gov/show/NCT00535171 | Completed | Sanofi | 2008-08-31 |
| NCT00523614 | Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00523614 | Completed | Center for Epidemiology and Health Research, Germany | NA |
| NCT00511784 | Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives. | https://ClinicalTrials.gov/show/NCT00511784 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06-30 |
| NCT00456196 | Epidemiology of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00456196 | Completed | Brigham and Women’s Hospital | 2009-06-30 |
| NCT00377988 | A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control | https://ClinicalTrials.gov/show/NCT00377988 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-10-31 |
| NCT00331071 | Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks | https://ClinicalTrials.gov/show/NCT00331071 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-03-31 |
| NCT00266045 | D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence | https://ClinicalTrials.gov/show/NCT00266045 | Completed | St. Orsola Hospital | 2008-06-30 |
| NCT02833987 | Direct Oral Anticoagulants and Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT02833987 | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 2015-03-31 |
| NCT00201903 | The Roles of Tissue Factor in Malignant Gliomas | https://ClinicalTrials.gov/show/NCT00201903 | Completed | Ontario Clinical Oncology Group (OCOG) | NA |
| NCT00063518 | Monitoring Trends in Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00063518 | Completed | University of Massachusetts, Worcester | 2007-12-31 |
| NCT00011180 | Risk Factors for Venous Thromboembolism in the Community | https://ClinicalTrials.gov/show/NCT00011180 | Completed | Mayo Clinic | 2009-05-31 |
| NCT00005684 | Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis | https://ClinicalTrials.gov/show/NCT00005684 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
| NCT00005543 | Genetic Epidemiology of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00005543 | Completed | Mayo Clinic | 2005-06-30 |
| NCT00005515 | Mutations, Hormone Therapy (HRT) and Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00005515 | Completed | University of Washington | NA |
| NCT00005496 | Inflammation, Infection, and Future Cardiovascular Risk | https://ClinicalTrials.gov/show/NCT00005496 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
| NCT00005351 | Incidence and Outcomes of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT00005351 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT02950168 | Edoxaban Management in Diagnostic and Therapeutic Procedures | https://ClinicalTrials.gov/show/NCT02950168 | Completed | Daiichi Sankyo, Inc. | 2018-07-26 |
| NCT02832245 | Computerized Registry of Patients With Venous Thromboembolism (RIETE) | https://ClinicalTrials.gov/show/NCT02832245 | Recruiting | Foundation for the study of VTE diseases. (FUENTE) | 2026-12-31 |
| NCT02546817 | Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS | https://ClinicalTrials.gov/show/NCT02546817 | Completed | Bristol-Myers Squibb | 2017-09-29 |
| NCT02219984 | START-Register: Survey on Anticoagulated Patients Register | https://ClinicalTrials.gov/show/NCT02219984 | Recruiting | St. Orsola Hospital | 2023-07-31 |
| NCT02213978 | A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients | https://ClinicalTrials.gov/show/NCT02213978 | Recruiting | Beijing Chao Yang Hospital | 2020-01-31 |
| NCT02155491 | Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events | https://ClinicalTrials.gov/show/NCT02155491 | Active, not recruiting | Thrombosis Research Institute | 2020-01-04 |
| NCT02079584 | Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant | https://ClinicalTrials.gov/show/NCT02079584 | Recruiting | Indiana University | 2020-03-31 |
| NCT01984190 | Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty | https://ClinicalTrials.gov/show/NCT01984190 | Completed | Medical Compression Systems | 2011-10-31 |
| NCT01744431 | Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients | https://ClinicalTrials.gov/show/NCT01744431 | Completed | HaEmek Medical Center, Israel | 2013-09-30 |
| NCT04124159 | Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT04124159 | Recruiting | Medical University of Vienna | 2023-12-31 |
| NCT04042155 | Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) | https://ClinicalTrials.gov/show/NCT04042155 | Recruiting | Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau | 2022-08-01 |
| NCT03881345 | Ongoing Registry of Treatment of Venous Thromboembolism | https://ClinicalTrials.gov/show/NCT03881345 | Recruiting | Medalp Private Surgery Clinic | 2036-03-01 |
| NCT03660007 | Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer | https://ClinicalTrials.gov/show/NCT03660007 | Completed | Karolinska Institutet | 2012-12-31 |
| NCT04195113 | Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry | https://ClinicalTrials.gov/show/NCT04195113 | Recruiting | McMaster University | 2022-08-31 |